A phase 1b trial of SENS-111 in severe bouts patients with vertigo

Trial Profile

A phase 1b trial of SENS-111 in severe bouts patients with vertigo

Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs SENS 111 (Primary)
  • Indications Vertigo
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Sensorion
  • Most Recent Events

    • 14 Dec 2016 According to a Sensorion media release, data will be presented at the 40th Association for Research in Otolaryngology (ARO) MidWinter Meeting 2017.
    • 01 Sep 2016 According to Sensorion media release, results from this study will be presented at The European Association for Clinical Pharmacology and Therapeutics (EACPT).
    • 12 May 2016 According to Sensorion media release, data will be presented at the American Academy of Otolaryngology-Head and Neck Surgery Foundation's 2016 Annual Meeting & OTO EXPO.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top